Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
29.65
+0.59 (2.03%)
May 4, 2026, 4:00 PM EDT - Market closed
Tectonic Therapeutic Employees
Tectonic Therapeutic had 60 employees as of December 31, 2025. The number of employees increased by 9 or 17.65% compared to the previous year.
Employees
60
Change (1Y)
9
Growth (1Y)
17.65%
Revenue / Employee
n/a
Profits / Employee
-$1,235,850
Market Cap
558.86M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 60 | 9 | 17.65% |
| Dec 31, 2024 | 51 | 7 | 15.91% |
| Mar 31, 2024 | 45 | - | - |
| Dec 31, 2023 | 44 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Ginkgo Bioworks Holdings | 485 |
| ProKidney | 231 |
| Rigel Pharmaceuticals | 174 |
| Entrada Therapeutics | 152 |
| Kyverna Therapeutics | 130 |
| Aura Biosciences | 113 |
| Prothena Corporation | 67 |
TECX News
- 11 days ago - Tectonic Therapeutic Appoints Jessica Chutter to Board of Directors - GlobeNewsWire
- 7 weeks ago - Tectonic Therapeutic Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Tectonic Therapeutic Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Tectonic Therapeutic Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 2 months ago - Tectonic Therapeutic Transcript: KOL event - Transcripts
- 2 months ago - Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board - GlobeNewsWire
- 2 months ago - Tectonic Therapeutic to Host Virtual KOL Event and Discussion of TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia, on February 24, 2026 - GlobeNewsWire
- 5 months ago - Tectonic Therapeutic Transcript: Piper Sandler 37th Annual Healthcare Conference - Transcripts